BioSpecifics Tech (BSTC) Posts Surprising Q4 Profit
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Join SI Premium – FREE
BioSpecifics Technologies Corp. (Nasdaq: BSTC) reported Q4 EPS of $0.02, $0.06 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.38 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
